Today from Vox...3 Jun 2020 20:13
COVID-19 Index Update
Vox Markets has highlighted UK Companies well-placed to trade strongly through the Coronovirus pandemic with our "COVID-19 Crusaders" index.
The index aims to shine a spotlight on small-cap healthcare companies, advancing the development of novel vaccines, technology companies enabling this new remote-working world, and support service companies that through their distance learning platforms or eSports offerings make the lockdown just a little bit more bearable.
Since inception of the index on 30 March 2020, the VOX Markets COVID-19 Index has performed strongly overall. However, the last two weeks in particular have seen the index retrace some of its gains as certain companies share prices fall predominantly on the lack of news relating to their COVID-19 activities.
Omega Diagnostics currently tops the top performers to date after it said the UK Rapid Test Consortium has made "significant progress" in developing a Covid-19 lateral flow antibody test that can be used by people at home.
The test kit supplier is a part of the consortium which has been led by Abingdon Health and also involved BBI Solutions and CIGA Healthcare, working in conjunction with the University of Oxford.
However, special mention must go to Avacta Group, which up until earlier this week had seen its shares top 200p and therefore would have topped our leader board.
However, the shares have retraced down to 130p over the past couple of trading days leaving it in a very respectable 2nd place.
Outside of the Biotec sector, we note that Totally has seen consistent recorded weekly gains in its share price as one of the UK’s largest out-of-hospital care providers delivering high-quality planned, urgent and insourcing healthcare across the UK and Ireland.
The Group recently said it is providing a number of additional services to support the NHS as they deal on the frontline with the Covid-19 outbreak